 REDWOOD CITY, Calif., June 22, 2021 PRNewswire -- Nevro Corp. NYSE: NVRO, a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that data from the SENZA Non-Surgical Refractory Back Pain NSRBP Randomized Controlled Trial RCT will be presented at the American Society of Interventional Pain Physicians ASIPP 23rd annual meeting to be held in person from June 24-26, 2021 at the Hilton New Orleans Riverside in New Orleans, Louisiana. 